The Genetics and Outcomes of an Altered FGF23-1,25D-PTH Axis in Diseases of Mineral Metabolism
{{output}}
The molecular mechanisms causing heritable disorders of hypo- and hyperphosphatemia involving the osteocyte-derived hormone fibroblast growth factor 23 (FGF23) and its co-receptor αKlotho (KL) have sprung new concepts underlying the endocrine control of phosp... ...
